Foreign direct investment in Singapore: the case of Pharmaceutical & Biological Products sector. Catallaxy, [S. l.], v. 9, n. 1, p. 7–15, 2024. DOI: 10.24136/cxy.2024.001. Disponível em: https://journals.economic-research.pl/cxy/article/view/3330. Acesso em: 6 dec. 2024.